These data may open the door for new therapeutic

Science (July 14, 2008)

damage to brain tissue as Huntington's disease may be caused by overactive immune response in blood and brain, according to new results of two teams of researchers from the University of Washington in Seattle and University College of London. Results will be published online July 14 in the Journal of Experimental Medicine. Working separately, two teams found evidence in both brain and blood cells suggests an important link between the immune system and Huntington's disease. Together, the results may help scientists find biological markers for monitoring disease progression earlier and with greater accuracy and can assist them in developing new treatments for this disease. Huntington is a fatal inherited neurodegenerative disorder for which there is currently no effective treatment. UW team led by Dr. Thomas Mueller, Research Associate Professor of Neurology, previously studied the role of inflammation and immune response in neurodegenerative diseases like Huntington's and ALS, also known as Lou Heriha disease. In this study, they found that patients with Huntington's had higher levels of immune system signaling molecules called cytokines in brain tissue. UW researchers looked at a mouse-oriented model of the disease by studying the reaction of microglia, immune cells of the nervous system. When microglia were treated starting molecule of the immune response in mice microglia Huntington produced much higher levels of cytokines, molecules of the immune system. This finding suggests that the protein produced by the Huntington's disease genetic mutation, a protein called Huntingtin, causes immune cells to be hyperactive. Researchers believe that too strong an immune response may be the mechanism by which this disease causes damage to neurons in the brain. When we found increased levels of cytokines in the brain of patients with Huntington's disease, we were very pleased, said Moller. Inflammation in the brain are increasingly recognized as an important component in other neurodegenerative diseases such as Alzheimer's or Parkinson's disease. These data may open the door for new therapeutic approaches for Huntington's disease that goal inflammation. The team from University College London focused their work on immune cells in the blood, and obtained similar results link the disease of the immune response of the body. A similar effect in patients with Huntington's that we have opened a new path in disease that mutant protein may cause damage, Moeller explained. Protein may cause damage through an abnormally overactive immune system, both in blood and brain. While damage from Huntington, usually seen in the brain, this new path is quite easy to detect in the blood of patients, so we may have found a unique window of blood that makes disease in the brain. Immune responses in the blood may also help researchers use immune system molecules of biological markers of disease that may be difficult to diagnose early. Better tracking the progression of Huntington's disease can help researchers to set up measures aimed at slowing the disease before it is reflected as brain tissue. Hentynhtona affects about 30,000 people in the United States. It is characterized by loss of motor control and cognitive function and depression or other mental disorders. And the UW and University College London research projects were supported by CHDI, Inc, a nonprofit organization that provides funds for medical research Huntington. Recommend this story on Facebook, Twitter

,

and Google +1: Other Bookmark and collaboration: History Source: above story is reprinted with provided through, services AAAS. Note: materials may be edited for content and length. For more information, please contact the source listed above. Warning: This article is not intended for medical advice, diagnosis or treatment. The views expressed here do not necessarily reflect the views of science most common side effects of lasix and its employees. .

Studies have shown a significant increase

There are a number of drugs for the prevention and treatment of osteoporosis. If you have osteoporosis or low bone density, please look at each of these drugs carefully with your doctor. REMEMBER: All medications must enough calcium, vitamin D and exercise work best. Bisphosphonates are used in the prevention and treatment of osteoporosis. They can help prevent fractures of the spine, hip and wrist in people with osteoporosis and prevent bone loss in men and women who take lasix 40 mg iv steroids. Bisphosphonates work, slowing down the cells that destroy bone (osteoclasts), which allows cells that build bone (osteoblasts) to work longer and reduce the imbalance. Actonel ^ ^ and also Fosamax was approved by the FDA for the treatment of osteoporosis in men. Etidronat (Didronel ^) was the first bisphosphonates used in the clinic in the U.S. and was approved for the treatment of disease Pagets, but not for the treatment of osteoporosis. Side effects of bisphosphonates can include muscle pain, joint pain, indigestion or heartburn. In a small number of cases, necrosis of the jaw (ONJ) ​​reported .. There are few reported cases of unusual fractures that occur in the middle of the thigh of patients with bisphosphonates. Learn more about hip fractures and the risk of drug use in BONESENSE. IMPORTANT: Follow the instructions for taking bisphosphonates: Bisphosphonates hard for your stomach to absorb. Thus, for maximum effectiveness, follow these steps:

Take the first morning on an empty stomach. Take the tablets with 8 OZ full glass of water. Do not use orange juice, coffee or any other drink I take the medicine. Do not eat or drink fluids at least 30 minutes. Remain sitting or standing (no lie) 30 minutes after ingestion. For years, hormone therapy (HT) was considered a panacea for women, adapting to the changes of menopause and to prevent health. Despite the obvious benefits to the bone, HT may introduce other risks for some women. Estrogen is indicated for the prevention of osteoporosis, but not for the treatment of osteoporosis. Decisions on individual decision-HT and complex. Currently, the recommendation to accept the low dose as soon as possible the symptoms of menopause. Talk to your doctor about the risks and benefits, including long-term effects. It is important to evaluate the pros and cons on an annual basis with your doctor. North American Menopause Society has more about hormone therapy. HT carried out in several ways, including orally or through the skin, gels and lotions. Side effects: HT associated with a slightly increased risk of breast cancer, stroke and deep vein thrombosis. Brands: Premarin ^ ^ Estrace, Ogen ^ ^ Cenestin, Climara ^ Vivelle-Dot ^ ^ Menostar and others. Parathyroid hormone is an anabolic treatment of osteoporosis that stimulates new bone growth and reduces the risk of fractures. PTH is usually reserved for people with severe osteoporosis. Studies have shown a significant increase in bone mineral density and reduce the large fractures. PTH daily injections of insulin, which is prescribed for 12-24 months. Forteo is designed for men and in postmenopausal women suffering from osteoporosis who are at high risk of fractures. Make: Side effects: may include dizziness and leg cramps. Denasumab is the first in its class, as a biological treatment for osteoporosis and by injection every six months. It works by reducing the activity of osteoclasts, cells that break bones, helping bone building cells to increase bone mass and strength. IsPbeing drug is recommended for women with osteoporosis and high risk of fractures, which includes patients who had osteoporotic fractures, there are several risk factors, or not responded to other treatments. Make: Side effects: may include back pain and muscle pain in the limbs, the height of the polynomial P lipids in the blood and bladder. SERMs, which are often called designer estrogens belong to the family of drugs made in the laboratory. They have some effects similar to estrogen on bone, cholesterol and other fats in the blood. SERMs reduce the influence of estrogen on certain tissues like the breast and uterus, and can be used with people who are at risk of developing these cancers. SERMs can reduce the risk of breast cancer and lower cholesterol. Research is being done to better understand these effects. One SERM, Evista ^ (raloksifen), was approved for the prevention and treatment of osteoporosis. Evista ^ has been shown to help prevent bone loss in the hip and spine fractures and lower spine. There are many promising new SERMS in clinical trials for prevention and treatment of osteoporosis. Evista ^ available in tablet form. Make: Side effects: may include hot flashes, cramping calf muscles and blood clots. SERMs generally do not cause bloating, breast, or bleeding from the uterus. Calcitonin is a hormone that can be found in the human body that helps with bone metabolism and calcium regulation. This can slow bone loss in the spine and spinal increase bone density and may help reduce the risk of fractures of the spine and help reduce the pain of fractures. He was not shown to prevent bone loss and fractures in other parts of the body. Calcitonin is given as a nasal spray or by injection. Make: Side effects: may include a runny nose with nasal spray or allergic reactions or other effects of injection form. .